This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Helsinki. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Ari Rouhiainen in Neuronal Injury Treatment
Introduction
Ari Rouhiainen is an accomplished inventor based in Helsinki, Finland. He has made significant contributions to the field of neuroscience, particularly in the treatment of neuronal injuries. With a total of two patents to his name, Rouhiainen's work focuses on innovative methods for promoting neural regeneration.
Latest Patents
Ari Rouhiainen's latest patents include a groundbreaking invention related to the treatment of neuronal injury. This invention discloses a novel use of an agent and a method for promoting neurite outgrowth and/or neural regeneration in central nervous system (CNS) injuries. The patent reveals a novel mechanism that enhances neurite outgrowth by increasing the interaction of chondroitin sulphate proteoglycan (CSPG) with receptor protein tyrosine phosphatase sigma (RPTPσ). This innovative approach has the potential to significantly impact the treatment of neuronal injuries.
Career Highlights
Ari Rouhiainen is affiliated with the University of Helsinki, where he conducts research and develops his inventions. His work is characterized by a strong focus on advancing the understanding of neuronal injuries and finding effective treatments.
Collaborations
Ari collaborates with notable colleagues, including Heikki Rauvala and Mikhail Paveliev. These partnerships enhance the research and development of innovative solutions in the field of neuroscience.
Conclusion
Ari Rouhiainen's contributions to the treatment of neuronal injuries through his innovative patents demonstrate his commitment to advancing medical science. His work at the University of Helsinki and collaborations with esteemed colleagues further solidify his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
